|
|
|
Insider
Information: |
Dunn John Michael |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
36,637 |
|
Indirect Shares
|
160 |
|
|
Direct
Value |
$5,747,400 |
|
|
Indirect Value
|
$37,053 |
|
|
Total
Shares |
36,797 |
|
|
Total
Value |
$5,784,453 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
Percentage
Gain/Loss : |
-17.8%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biogen Idec Inc |
BIIB |
EVP, New Ventures |
2009-02-24 |
24,752 |
2005-12-22 |
160 |
Premium* |
|
Immunic Inc |
IMUX |
General Counsel and Se... |
2017-06-14 |
11,885 |
2015-10-23 |
0 |
Premium* |
|
Acer Therapeutics Inc |
ACER |
Director |
2023-11-17 |
0 |
2017-09-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
61 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BIIB |
Biogen Idec Inc |
EVP - New Ventures |
|
2004-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
10,990 |
11,609 |
|
- |
|
BIIB |
Biogen Idec Inc |
EVP, New Ventures |
|
2006-09-14 |
4 |
A |
$0.00 |
$0 |
D/D |
20,650 |
33,673 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP, New Ventures |
|
2007-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
26,216 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP, New Ventures |
|
2007-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
7,346 |
31,228 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP, New Ventures |
|
2008-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
10,430 |
26,223 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP, New Ventures |
|
2008-02-12 |
4/A |
A |
$0.00 |
$0 |
D/D |
10,430 |
28,490 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP, New Ventures |
|
2009-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
6,040 |
24,752 |
0 |
- |
|
ACER |
Acer Therapeutics Inc |
|
|
2017-09-19 |
4 |
A |
$0.00 |
$0 |
D/D |
5,952 |
5,952 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP, New Ventures |
|
2004-12-09 |
4 |
AS |
$65.00 |
$325,000 |
D/D |
(5,000) |
53,202 |
|
- |
|
BIIB |
Biogen Idec Inc |
EVP, New Ventures |
|
2006-10-31 |
4 |
AS |
$46.79 |
$613,119 |
D/D |
(13,104) |
26,127 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP, New Ventures |
|
2006-10-31 |
4/A |
AS |
$46.72 |
$1,314,444 |
D/D |
(28,104) |
13,023 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP, New Ventures |
|
2006-11-15 |
4 |
AS |
$49.00 |
$384,650 |
D/D |
(7,850) |
26,127 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP, New Ventures |
|
2007-02-13 |
4 |
AS |
$49.22 |
$114,870 |
D/D |
(2,334) |
23,882 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP, New Ventures |
|
2007-04-20 |
4 |
AS |
$45.99 |
$345,997 |
D/D |
(7,519) |
21,389 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP, New Ventures |
|
2007-04-23 |
4 |
AS |
$48.90 |
$917,364 |
D/D |
(18,760) |
17,629 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP, New Ventures |
|
2007-06-27 |
4 |
AS |
$52.90 |
$812,121 |
D/D |
(15,352) |
17,629 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP, New Ventures |
|
2007-07-25 |
4 |
AS |
$57.75 |
$1,155,000 |
D/D |
(20,000) |
17,629 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP, New Ventures |
|
2008-02-12 |
4 |
AS |
$60.46 |
$138,202 |
D/D |
(2,267) |
15,793 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP, New Ventures |
|
2008-02-12 |
4/A |
AS |
$60.46 |
$138,202 |
D/D |
(2,267) |
26,223 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP, New Ventures |
|
2008-04-14 |
4 |
AS |
$64.06 |
$206,196 |
D/D |
(3,212) |
23,404 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP, New Ventures |
|
2008-07-21 |
4 |
AS |
$67.50 |
$437,738 |
D/D |
(6,485) |
24,988 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP, New Ventures |
|
2008-07-22 |
4 |
AS |
$71.50 |
$463,678 |
D/D |
(6,485) |
24,988 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP, New Ventures |
|
2009-02-11 |
4 |
AS |
$50.81 |
$114,729 |
D/D |
(2,258) |
24,956 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP, New Ventures |
|
2009-02-19 |
4 |
AS |
$50.90 |
$163,301 |
D/D |
(3,208) |
18,712 |
0 |
- |
|
IMUX |
Immunic Inc |
General Counsel and Secretary |
|
2015-10-23 |
4 |
B |
$6.76 |
$49,933 |
D/D |
7,385 |
7,385 |
2.74 |
- |
|
61 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|